Lovelace biomedical research institute (RADNUC) - IDIQ for barda CRN animal model development
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75A50122D00013
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Task orders
- 1 $5,905,018 obligated
Award facts
- Opportunity
-
- BARDA Radiological and Nuclear (RADNUC) Animal Model and Medical Countermeasures (MCM) Development Pre-Solicitation · 75A50121R00017 · Posted Feb 1, 2021
- Combined order value
-
- $5,905,018 Current, with exercised options
- $8,829,095 Potential, with all options
- Last date to order 83% complete
- IDV ceiling 6% used
- $100,000,000.00
- Maximum order
- $100,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
Award details come from SAM.gov/FPDS.
About this IDV
The Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $100 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization based in Albuquerque, New Mexico, for biological animal model development and medical countermeasure testing in support of the Biomedical Advanced Research and Development Authority's radiological and nuclear preparedness mission. The contract, awarded on September 9, 2022, with an ultimate completion date of September 8, 2027, was issued without a small business set-aside designation. The originating pre-solicitation notice, posted February 1, 2021, sought proposals from Good Laboratory Practice-certified facilities capable of establishing or utilizing existing animal models for radiological and nuclear medical countermeasures development. Qualified proposers were required to demonstrate federal and state licensure for irradiation, select agents certifications, AAALAC International accreditation, United States Department of Agriculture certification, completion of prior Good Laboratory Practice studies, and capability to support at least two animal model species including a large animal model.
Under this IDIQ vehicle, Lovelace has performed work including a $8.68 million delivery order (RADNUC 2201) issued September 29, 2023, for performance verification of institutional radiation dose response in acute radiation syndrome animal models across rodents, rabbits, minipigs, and non-human primates, with completion targeted for September 18, 2026. This delivery order employs cost-plus-fixed-fee pricing and supports the validation of radiation dose response protocols necessary for medical countermeasure development and evaluation in response to potential radiation exposure incidents. The contract work is performed in Albuquerque, New Mexico, leveraging Lovelace's extensive experience in preclinical research, animal model development, and medical countermeasure testing across multiple federal agencies including the National Institutes of Health, Food and Drug Administration, and National Institute of Allergy and Infectious Diseases.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Radnuc 2201: performance verification of institutional radiation dose response for acute radiation syndrome (ARS)… | Office of the Assistant Secretary for Preparedness and Response | $5,905,018 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $75,000 |
Quick answers
Who was awarded contract 75A50122D00013?
75A50122D00013 was awarded to Lovelace Biomedical Research Institute by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 9, 2022.
How much is contract 75A50122D00013 worth?
Orders under 75A50122D00013 have obligated $5,905,018. Their combined potential value, with all options, is $8,829,095. 75A50122D00013's own ceiling is $100,000,000. A single order can be worth up to $100,000,000.
How many orders have been placed under contract 75A50122D00013?
1 order has been placed under 75A50122D00013, the latest on September 29, 2023.
Who can order from contract 75A50122D00013?
75A50122D00013 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75A50122D00013 competed?
The extent of competition for 75A50122D00013 was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV